The role of EGFR signalling, and in particular of EGFR ligands, in osteoclastogenesis is known from breast cancer co-culture models and non-small cell lung cancer (NSCLC) models, where EGFR inhibition with TKIs was shown to prevent osteoclast differentiation [122,123,124]. Here, EGFR is linked to breast carcinoma.